Sleeping sickness and the central nervous system

Chronic African trypanosomiasis is associated with progressive behavioural deficits, for which there is a complex underlying central nervous system (CNS) pathology. This has been extensively studied in man and a range of experimental animals. An initial meningitis, which can occur quite early in the infection, is followed by a breakdown of the choroid plexus, movement of the parasite into certain localized brain areas, and subsequent encephalitis. The encephalitis consists of a chronic, widespread inflammation with perivascular infiltrations of B-cells, plasma cells, inactivated T-cells and macrophages. The blood-brain barrier is damaged and a vasogenic oedema ensues. Astrocytes and microglia become reactive and the cytokine/mediator network is perturbed. The alterations in some of these signalling substances, e.g. the prostaglandins, may induce some of the behavioural changes, e.g. the hypersomnia. The immunopathology in the CNS may be brought about by elevated levels of active substances in the cerebrospinal fluid, caused by parasite infection.The articles have been scanned in colour with a HP Scanjet 5590; 600dpi. Adobe Acrobat XI Pro was used to OCR the text and also for the merging and conversion to the final presentation PDF-format.UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.mn201

Heat treatment of organics for increasing anaerobic biodegradability. Quarterly progress report, July 1, 1979-September 30, 1979

The objective of this study is to evaluate thermochemical pretreatment as a method for increasing the anaerobic biodegradability of organic materials so that they can be more completely fermented to methane gas, a potential source of fuel. The current study has four specific phases: (1) biological conversion of lignocellulose to methane, (2) biodegradation of lignin and lignin fractions, (3) pretreatment of nitrogenous organics for increasing biodegradability, (4) biodegradation of lignin aromatic compounds, and (5) biochemical methane potential and toxicity testing. Results are reported for phases one, two, and three. No new information is available for phases four and five at this time